[{"_id":"551f89b631cae9239deb1ef3","会社名":"持田製薬(株)【4534】","証券コード":"4534","決算期":"2014年3月期","会計方式":"日本方式","決算発表日":"2014年5月12日","決算月数":"12か月","売上高":"93,947百万円","営業利益":"16,600百万円","経常利益":"16,799百万円","当期利益":"9,892百万円","EPS（一株当たり利益）":"488.66円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"4,665.16円","総資産":"130,669百万円","自己資本":"93,688百万円","資本金":"7,229百万円","有利子負債":"875百万円","自己資本比率":"71.7%","ROA（総資産利益率）":"7.87%","ROE（自己資本利益率）":"10.86%","総資産経常利益率":"13.36%","__v":0,"日付":"2015-04-04T06:50:30.816Z"},{"_id":"551f89b631cae9239deb1ef4","会社名":"持田製薬(株)【4534】","証券コード":"4534","決算期":"2013年3月期","会計方式":"日本方式","決算発表日":"2013年5月13日","決算月数":"12か月","売上高":"89,210百万円","営業利益":"14,017百万円","経常利益":"14,188百万円","当期利益":"9,152百万円","EPS（一株当たり利益）":"88.45円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"861.47円","総資産":"120,828百万円","自己資本":"88,542百万円","資本金":"7,229百万円","有利子負債":"875百万円","自己資本比率":"73.3%","ROA（総資産利益率）":"7.83%","ROE（自己資本利益率）":"10.72%","総資産経常利益率":"12.14%","__v":0,"日付":"2015-04-04T06:50:30.816Z"},{"_id":"551f89b631cae9239deb1ef5","会社名":"持田製薬(株)【4534】","証券コード":"4534","決算期":"2012年3月期","会計方式":"日本方式","決算発表日":"2012年5月14日","決算月数":"12か月","売上高":"86,205百万円","営業利益":"14,928百万円","経常利益":"15,286百万円","当期利益":"9,076百万円","EPS（一株当たり利益）":"86.09円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"793.13円","総資産":"112,871百万円","自己資本":"82,189百万円","資本金":"7,229百万円","有利子負債":"875百万円","自己資本比率":"72.8%","ROA（総資産利益率）":"8.20%","ROE（自己資本利益率）":"11.32%","総資産経常利益率":"13.81%","__v":0,"日付":"2015-04-04T06:50:30.816Z"}]